Type IV renal tubular acidosis and spironolactone therapy in the elderly.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 8290440.
- Also identified by PMC identifier 2399924.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Spironolactone therapy is a well-known cause of hyperkalaemia, but in susceptible patient, it may also be associated with metabolic acidosis. We report a case of severe renal tubular acidosis (Type IV) with life-threatening hyperkalaemia caused by spironolactone, and discuss the mechanisms by which this may occur.
Medical subject headings
- Acidosis, Renal Tubular
- Spironolactone